Overview

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Status:
Completed

Trial end date:
2003-08-01

Target enrollment:

Participant gender:

Summary

To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.

Phase:

Phase 2

Details

Lead Sponsor:

Alcon Research